Masayuki Kato

发表

Treatment with valproic acid for myelofibrosis with myeloid metaplasia

Masatomo Takahashi, Y. Inoue, Takao Suzuki, 2005, Annals of Hematology.

Light-chain plasma cell myeloma caused by 14q32/IGH translocation and loss of the other allele

I. Miura, Masayuki Kato, Y. Nishio, 2019, International Journal of Hematology.

Cell dynamics during differentiation therapy with all-trans retinoic acid in acute promyelocytic leukemia

I. Miura, Y. Inoue, Masayuki Kato, 2018, International Journal of Hematology.

Pharmacokinetics of Cyclosporine a Conversion From Twice-Daily Infusion to Oral Administration in Allogeneic Hematopoietic Stem Cell Transplantation

I. Miura, Tasuku Saito, Masatomo Takahashi, 2014, American journal of therapeutics.

Close relation between 14q32/IGH translocations and chromosome 13 abnormalities in multiple myeloma: a high incidence of 11q13/CCND1 and 16q23/MAF

I. Miura, H. Sugimori, Tasuku Saito, 2008, International journal of hematology.

Double-hit lymphomas and complex variant translocations of t(14;18)(q32;q21.3)

I. Miura, Masayuki Kato, 2013, Annals of Hematology.

Transforming growth factor-beta overexpression in cutaneous extramedullary hematopoiesis of a patient with myelodysplastic syndrome associated with myelofibrosis.

T. Kawakami, Masayuki Kato, Y. Soma, 2008, Journal of the American Academy of Dermatology.

Spontaneous remission in a patient with follicular lymphoma carrying T cell-rich neoplastic follicles and a new complex variant translocation of t(14;18): t(5;14;18)(p15;q32;q21.3)

N. Nakamura, I. Miura, Tasuku Saito, 2015, Leukemia & lymphoma.

Role of serum high mobility group box 1 in hematological malignancies complicated with systemic inflammatory response syndrome and effect of recombinant thrombomodulin

I. Miura, Tasuku Saito, Masatomo Takahashi, 2013, Leukemia & lymphoma.

De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a case report and literature review

M. Takagi, I. Miura, Masayuki Kato, 2017, BMC Clinical Pathology.

[Leukemic cell kinetics of APL with a novel complex variant t (12;17;15)(p13;q21;q22)].

I. Miura, A. Arai, Masayuki Kato, 2020, [Rinsho ketsueki] The Japanese journal of clinical hematology.

3q26.2/EVI1の単純変異転座t (3;8) (q26.2;q24)を伴う急性骨髄性白血病

I. Miura, Y. Inoue, Masayuki Kato, 2017 .

Biopsy remains indispensable for evaluating bone marrow involvement in DLBCL patients despite the use of positron emission tomography

N. Nakamura, I. Miura, A. Arai, 2021, International Journal of Hematology.

Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study

T. Naoe, T. Kyo, S. Horiike, 2010, International journal of hematology.

Cytogenetic Study and Analysis of Protein Expression in Plasma Cell Myeloma with t(11;14)(q13;q32): Absence of BCL6 and SOX11, and Infrequent Expression of CD20 and PAX5.

I. Miura, Y. Inoue, Masayuki Kato, 2015, Journal of clinical and experimental hematopathology : JCEH.

PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32)

I. Miura, Tasuku Saito, Masatomo Takahashi, 2015, International Journal of Hematology.

Pharmacokinetics of cyclosporine A at a high‐peak concentration of twice‐daily infusion and oral administration in allogeneic haematopoietic stem cell transplantation

Y. Suzuki, Tasuku Saito, M. Takahashi, 2011, Journal of clinical pharmacy and therapeutics.

Recombinant thrombomodulin improved Stevens-Johnson syndrome with high serum high-mobility group-B1 DNA-binding protein induced by lenalidomide administered to treat multiple myeloma.

I. Miura, Tasuku Saito, Masatomo Takahashi, 2013, Thrombosis research.